미국 신문 비지니스 1면 헤드라인 모음 11/10 화 (영문)

안녕하세요.

질문이 있으시거나 수정할 내용 발견하시면 댓글에 적어주세요.

감사합니다.

• [[Los Angeles Times]]
  • Judge says she was fired after objecting to insurer settlements
    • California agency allegedly avoided her rate hike reviews
    • California Insurance commissioner Ricardo Lara is accused in a lawsuit of violating Proposition 103.
  • Gunn, Safran depart as DC Studios heads
    • Peter Safran, and James Gunn led DC Studios to a mixed record after a strong start in "Superman."
  • Skydance looks to cut more than $6 billion in integration

• [[USA Today]]
  • MACHINE PICKS
    • AI promises faster hiring, but concerns persist over who is left behind
  • Dems promise to act on health costs
    • ‘Medicare for All’ also pushed by progressives
  • Check your status under new 2027 IRS tax brackets

• [[The New York Times]]
  • Nvidia Stock Drops Even as Broader Market Rallies
    • The chip maker’s shares fell sharply after its C.E.O., Jensen Huang, admitted to a relationship with a businesswoman suspected of spying for China.
  • Commerce Dept. Chip Inquiry Was Halted After Nvidia Intervention
    • An investigation into Megaspeed, a Singapore company that was buying advanced Nvidia A.I. chips, was transferred to the Justice Department after a top Nvidia executive reached out to Commerce Department officials.
    • Nvidia said on Sunday that it was opening an investigation into Jensen Huang, after he acknowledged he had been intimate with an executive at a Singaporean company suspected of smuggling chips into China.
  • China Rejects Espionage Claims Involving Nvidia C.E.O. Jensen Huang
    • The controversy has intensified scrutiny of Mr. Huang’s ties to Beijing and sparked mixed reactions across Asia, where he is widely popular.
    • Jensen Huang, chief executive of the powerhouse chipmaker Nvidia, told its board of his intimate relationship with a business executive who U.S. officials suspect provided information to Chinese intelligence.
  • A.I. Turned Mundane Chipmakers Into Tech Celebrities
    • As chips became essential components for A.I., executives like Nvidia’s Jensen Huang saw their personal wealth and profiles soar in a way the industry has not experienced before.
    • Nvidia’s chief executive Jensen Huang at the company’s annual conference in San Jose in March.

• [[Wall Street Journal]]
  • Executives Exit Blackstone Realty
    • As business’s returns fall, an important part of managers’ pay drops as well
    • $300B
      • Blackstone’s realestate assets under management globally.
  • Talent War Meant End of Status Quo For Law Firms
    • A profession once marked by predictability and stability has been upended.
  • CEO Affair Rings Alarms
  • From Nuclear Power to Data Centers
    • From left, Adam Blake, Nick Poradek and Seth Cohen founded Mavria after working in the U.S. Energy Department.
  • Anthropic Plans IPO Despite Market Jitters
  • Skydance Shakes Up Superhero Studio Leadership

• [[Financial Times]] 영국에 위치한 니케이 소유 회사입니다.
  • Bot­swana to raise De Beers hold­ing to 30% amid Anglo plan to sell stake
    • Bot­swana will double its hold­ing in De Beers, the coun­try’s Pres­id­ent Duma Boko has announced, as he backed former chief exec­ut­ive Gareth Penny’s con­sor­tium to take over the strug­gling dia­mond miner from Anglo Amer­ican.
    • Bot­swana pro­duces about 70% of De Beers’ dia­monds. The group’s value has fallen to $2.3bn
  • Big Tech focus on ver­tical integ­ra­tion faces polit­ical wind of change
    • A leftwing shift in the US after the midterm elections could lead to a real effort to break up Big Tech
  • Alleged spy pitched Nvidia AI chips deal to investors
    • ▸ Exec­ut­ive boas­ted of access to GPUs ▸ US offi­cials make espi­on­age claims
    • The US believes Huang had relationship with a woman recruited by Chinese security agency
  • FDA orders warn­ing on GLP-1 drugs of sight loss risk
    • The US drug reg­u­lator said it will require makers of GLP-1 medi­cines to add a warn­ing to their labelling about the poten­tial increased risk of blind­ness asso­ci­ated with use of the pop­u­lar weight-loss drugs.